Eidos Therapeutics, Inc. Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eidos Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eidos Therapeutics, Inc. for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Option Exercise | M | 0.59 | 17,000 | 10,030 | 222,191 | |
| Jun 28 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Buy | M | 0.59 | 17,000 | 10,030 | 36,470 | 19.5 K to 36.5 K (+87.31 %) |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | AGUIAR ERIC | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | Lis William | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | AGUIAR ERIC | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | Lis William | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 07 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Sell | S | 31.03 | 300 | 9,309 | 19,470 | 19.8 K to 19.5 K (-1.52 %) |
| Jun 07 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Sell | S | 30.10 | 13,421 | 403,972 | 19,770 | 33.2 K to 19.8 K (-40.44 %) |
| Jun 07 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Sell | S | 29.34 | 3,279 | 96,206 | 33,191 | 36.5 K to 33.2 K (-8.99 %) |
| Jun 07 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Grant | A | 12.01 | 1,769 | 21,247 | 36,470 | 34.7 K to 36.5 K (+5.10 %) |
| Jun 07 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Sell | S | 31.03 | 300 | 9,309 | 19,470 | 19.8 K to 19.5 K (-1.52 %) |
| Jun 07 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Sell | S | 30.10 | 13,421 | 403,972 | 19,770 | 33.2 K to 19.8 K (-40.44 %) |
| Jun 07 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Sell | S | 29.34 | 3,279 | 96,206 | 33,191 | 36.5 K to 33.2 K (-8.99 %) |
| Jun 07 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Grant | A | 12.01 | 1,769 | 21,247 | 36,470 | 34.7 K to 36.5 K (+5.10 %) |
| Jun 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 32.27 | 3,300 | 106,491 | 100,155 | 103.5 K to 100.2 K (-3.19 %) |
| Jun 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 31.33 | 6,700 | 209,911 | 103,455 | 110.2 K to 103.5 K (-6.08 %) |
| Jun 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Grant | A | 12.01 | 1,769 | 21,246 | 110,155 | 108.4 K to 110.2 K (+1.63 %) |
| Jun 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Grant | A | 12.01 | 1,081 | 12,983 | 108,386 | 107.3 K to 108.4 K (+1.01 %) |